1.0
Aug 8, 2025
Former employee, more than 3 years
Rahway, NJ
Recommend
CEO approval
Business Outlook
Pros
Unfortunately, I cannot think of any.
Cons
In preclinical drug discovery especially computational chemistry and structural biology: Extremely Male-dominated leadership and culture Favoritism and gatekeeping, especially by senior male staff Women’s contributions routinely overlooked or credited to others Unfair authorship practices; others presenting and claiming your work Promotions are rare and career progression is blocked by excessive internal levels Lack of transparency and support for career development Innovation is discouraged; risk-averse, traditional scientific mindset